Laura Wood

I enclose details of our report on Leading Drug Delivery Companies and Technologies

Business Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business decisions.

We understand the problems facing today's pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of accurate, up-to-date, incisive product, market and company analysis. We help you to crystallize your business decisions.

The strength of our research and analysis is derived from access to unparalleled databases and libraries of information and the use of proprietary analytic techniques.

These reports are authored by independent experts and contain findings garnered from dedicated primary research. Our authors' leading positions secure them access to interview key executives and to establish which issues will be of greatest strategic significance for the industry.

Our healthcare portfolio of reports can be used across a wide range of business functions to assess market conditions and devise future strategy. Our reports cover key areas including strategy, industry analysis, market outlook, new business opportunities and strategic insight.

For more information please click on:
http://www.researchandmarkets.com/product/9fe962/leading_drug_delivery_companies_and_technolog

Some key findings from this report...
- The oral delivery system continues to dominate the drug delivery market due to convenient usage, cost-effectiveness and low frequency of administration. Needle less injectables, PEGylation technologies and micro-electromechanical devices are among the novel technologies with the greatest growth potential.

- The market for parenteral drugs and solutions sold in prefilled syringes and premixed IV systems will grow, due to the ease of administration and resistance to infections associated with these methods. The needle-free delivery sector will rise to $3bn by 2010.

- Pulmonary delivery technologies are increasingly prevalent in pain management, cystic fibrosis and diabetes. Pulmonary-based delivery vehicles are currently the focus of a number of major companies including Nektar, Aradigm, 3M, and Alkermes.

- Dry powder inhalers will secure the largest share of sales within the asthma market, as demand for treatments in this therapy area continues to expand. However, MDI products will experience a relatively higher rate of growth due to consistent improvements in particle size and safe propellant delivery.

Leading Drug Delivery Companies and Technologies
Over the last decade, the drug delivery industry has evolved to become a key area in the development of value-added pharmaceutical products.

The global market grew from $15bn to $40bn during 2000-2006 as companies increasingly turned to drug delivery technologies as a means of expanding product lifecycles, enhancing drug efficacy and maximizing revenues.

Although the market is still dominated by the oral drug delivery system, a number of novel technologies are emerging across all systems of delivery. However, the pure drug delivery company model is rapidly becoming extinct as leading players attempt to consolidate their strategic opportunities by expanding their focus towards manufacturing, a trend that is expected to accelerate over the next five years.

'Leading Drug Delivery Companies and Technologies' is a new report that examines the current and future trends that are shaping the drug delivery market and reviews the key emerging technologies across major systems of drug delivery.

This report identifies the product portfolios and targeted therapeutic areas of leading drug delivery companies in addition to assessing their technology platforms to provide guidance over their applicability, regulatory implications and developmental progress.

This report also evaluates the opportunities and threats facing each of the companies profiled and provides a comparative analysis of the growth strategies used to facilitate successful deals and collaborations.

Identify key trends and developments in the global drug delivery market, assess the performances and portfolios of leading drug delivery companies and benchmark their strategies with this new report...

Title Index:

Leading Drug Delivery Companies and Technologies

Executive Summary

Overview on drug delivery industry

Oral drug delivery system

Injectable drug delivery system

Pulmonary drug delivery system

Transdermal drug delivery system

Chapter 1 Overview of Drug Delivery Industry

Summary
What is this report about?
Methodology
Drug delivery overview
Role of drug delivery in the pharma landscape
Revenue boosters for pharma companies

Chapter 2 Oral Drug Delivery System

Summary
Synopsis
Oral drug delivery technologies
Technologies for fast-dissolving and taste-masking pills
Controlled oral drug delivery
Types of controlled release
Dynamics of oral drug delivery market
Biovail
Key technologies
Therapeutic focus

Chapter 3 Injectable Drug Delivery System

Summary
Synopsis
Injectable drug delivery technologies
Needleless injection device technology
Sustained/controlled release technology
PEGylation
Therapeutic focus
Dynamics of the injectable drug delivery market
Alkermes
Introduction
Key technologies
Medisorb injectable technology
AIR pulmonary drug delivery technology
Therapeutic focus

Chapter 4 Pulmonary Drug Delivery System

Summary
Synopsis
Inhaled formulations
Therapeutic focus
Dynamics of the pulmonary drug delivery market
Nektar Therapeutics
Key technologies
Dry powder pulmonary technology
Liquid pulmonary technology
PEGylation technology
Therapeutic focus
Product portfolio and pipeline candidates
Recent financial performance
Growth strategies

Chapter 5 Transdermal Drug Delivery System

Summary
Synopsis
Transdermal drug delivery technologies
Passive formulations
Active formulations
Therapeutic focus
Dynamics of the transdermal drug delivery market
Antares
Key technologies
Advanced transdermal delivery
Injection devices
Easy Tec fast melt oral disintegrating tablets
Therapeutic focus
Product portfolio and pipeline candidates
Recent financial performance
Growth strategies
Deals and alliances
SWOT analysis

Pricing:

Electronic (PDF) (Single User) : EUR 4103
Hard Copy : EUR 4200

Ordering - Three easy ways to place your order:

1] Order online at http://www.researchandmarkets.com/product/9fe962/leading_drug_delivery_companies_and_technolog

2] Order by fax: Print an Order form from http://www.researchandmarkets.com/product/9fe962/leading_drug_delivery_companies_and_technolog and Fax to +353 1 4100 980

3] Order by mail: Print an Order form from http://www.researchandmarkets.com/product/9fe962/leading_drug_delivery_companies_and_technolog and post to Research and Markets Ltd. Guinness Center, Taylors ***, Dublin 8. Ireland.

Related Titles also available from Research and Markets:

Transdermal Drug Delivery - Technologies, Markets, and Companies -
http://www.researchandmarkets.com/product/9fe962/transdermal_drug_delivery_technologies_mar

Drug Delivery in Cancer - Technologies, Markets and Companies -
http://www.researchandmarkets.com/product/9fe962/drug_delivery_in_cancer_technologies_marke

Thank you for your consideration.

Best Regards,

Laura Wood
Senior Manager
Research and Markets Ltd
laura.wood@researchandmarkets.com

Subscribe: Click on http://www.researchandmarkets.com/register.asp You can subscribe free for regular details on new research in your sector.

Please note you are currently subscribed as ralrusu@gmail.com

If you no longer wish to receive our market research updates, please reply to this message with Suppression Request as the subject line, or use the link below

http://www.researchandmarkets.com/u.asp?f=u&e=ralrusu@gmail.com

Back to newsletter list

Date:

From:

Subject:

Leading Drug Delivery Companies and Technologies